Abstract
Vortioxetine (VTX) is a recently approved antidepressant that targets a variety of serotonin receptors. Here, we investigate the drug’s molecular mechanism of operation at the serotonin 5-HT3 receptor (5-HT3R), which features two properties: VTX acts differently on rodent and human 5-HT3R, and VTX appears to suppress any subsequent response to agonists. Using a combination of cryo-EM, electrophysiology, voltage-clamp fluorometry and molecular dynamics, we show that VTX stabilizes a resting inhibited state of the mouse 5-HT3R and an agonist-bound-like state of human 5-HT3R, in line with the functional profile of the drug. We report four human 5-HT3R structures and show that the human receptor transmembrane domain is intrinsically fragile. We also explain the lack of recovery after VTX administration via a membrane partition mechanism.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The coordinates of the structures and the cryo-EM maps have been deposited with the Worldwide Protein Data Bank (wwPDB) and Electron Microscopy Data Bank (EMDB): m5-HT3AR in detergent in complex with VTX (EMDB-15689, PDB 8AW2), h5-HT3AR in detergent apo/resting (EMDB-15699, PDB 8AXD), h5-HT3AR in detergent active-distorted (EMDB-16103, PDB 8BL8), h5-HT3AR in detergent (EMDB-16104, PDB 8BLA), h5-HT3AR in nanodisc in complex with VTX (EMDB-16105, PDB 8BLB). All relevant data have been deposited in publicly available repositories. Simulation files have been deposited in Zenodo at https://doi.org/10.5281/zenodo.10663688. Source data are provided with this paper.
References
Bang-Andersen, B. et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J. Med. Chem. 54, 3206–3221 (2011).
Sanchez, C., Asin, K. E. & Artigas, F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol. Ther. 145, 43–57 (2015).
Nackenoff, A. G. et al. Serotonin transporter-independent actions of the antidepressant vortioxetine as revealed using the SERT Met172 mouse. ACS Chem. Neurosci. 8, 1092–1100 (2017).
Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y. & Keefe, R. S. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 41, 2961 (2016).
McIntyre, R. S., Lophaven, S. & Olsen, C. K. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int. J. Neuropsychopharmacol. 17, 1557–1567 (2014).
Pehrson, A. L. et al. Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. Eur. J. Pharmacol. 753, 19–31 (2015).
Riga, M. S., Sánchez, C., Celada, P. & Artigas, F. Involvement of 5-HT 3 receptors in the action of vortioxetine in rat brain: focus on glutamatergic and GABAergic neurotransmission. Neuropharmacology 108, 73–81 (2016).
Nemecz, À., Prevost, M. S., Menny, A. & Corringer, P.-J. Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels. Neuron 90, 452–470 (2016).
Barnes, N. M. et al. International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacol. Rev. 73, 310–520 (2021).
Niesler, B. 5-HT3 receptors: potential of individual isoforms for personalised therapy. Curr. Opin. Pharmacol. 11, 81–86 (2011).
Ladefoged, L. K. et al. Modeling and mutational analysis of the binding mode for the multimodal antidepressant drug vortioxetine to the human 5-HT3A receptor. Mol. Pharmacol. 94, 1421–1434 (2018).
Polovinkin, L. et al. Conformational transitions of the serotonin 5-HT3 receptor. Nature 563, 275–279 (2018).
Basak, S. et al. Cryo-EM structure of 5-HT 3A receptor in its resting conformation. Nat. Commun. 9, 514 (2018).
Basak, S., Gicheru, Y., Rao, S., Sansom, M. S. P. & Chakrapani, S. Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. Nature 563, 270–274 (2018).
Felt, K. et al. Structural basis for partial agonism in 5-HT3A receptors. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-023-01140-2 (2024).
Zhang, Y. et al. Asymmetric opening of the homopentameric 5-HT 3A serotonin receptor in lipid bilayers. Nat. Commun. 12, 1–15 (2021).
Zarkadas, E. et al. The binding of palonosetron and other antiemetic drugs to the serotonin 5-HT3 receptor. Structure 28, 1131–1140 (2020).
Basak, S. et al. High-resolution structures of multiple 5-HT3AR-setron complexes reveal a novel mechanism of competitive inhibition. eLife 9, e57870 (2020).
Dale, E. et al. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT3 receptor expressing interneurons: an in vitro study in rat hippocampus slices. Brain Res. 1689, 1–11 (2018).
Gielen, M. & Corringer, P.-J. The dual-gate model for pentameric ligand-gated ion channels activation and desensitization. J. Physiol. 596, 1873–1902 (2018).
Beene, D. L. et al. Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry 41, 10262–10269 (2002).
Xiu, X., Puskar, N. L., Shanata, J. A. P., Lester, H. A. & Dougherty, D. A. Nicotine binding to brain receptors requires a strong cation-pi interaction. Nature 458, 534–537 (2009).
Thompson, A. J. Recent developments in 5-HT3 receptor pharmacology. Structure 34, 100–109 (2013).
Laverty, D. et al. Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer. Nature 565, 516–520 (2019).
Kim, J. J. et al. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature 585, 303–308 (2020).
Talwar, S. & Lynch, J. W. Investigating ion channel conformational changes using voltage clamp fluorometry. Neuropharmacology 98, 3–12 (2015).
Cowgill, J. & Chanda, B. The contribution of voltage clamp fluorometry to the understanding of channel and transporter mechanisms. J. Gen. Physiol. 151, 1163–1172 (2019).
Munro, L. et al. Conformational changes in the 5-HT3A receptor extracellular domain measured by voltage-clamp fluorometry. Mol. Pharmacol. 96, 720–734 (2019).
Chang, Y. & Weiss, D. S. Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism. Nat. Neurosci. 5, 1163–1168 (2002).
Lefebvre, S. N., Taly, A., Menny, A., Medjebeur, K. & Corringer, P.-J. Mutational analysis to explore long-range allosteric couplings involved in a pentameric channel receptor pre-activation and activation. eLife 10, e60682 (2021).
Muroi, Y., Czajkowski, C. & Jackson, M. B. Local and global ligand-induced changes in the structure of the GABA(A) receptor. Biochemistry 45, 7013–7022 (2006).
Pless, S. A. & Lynch, J. W. Ligand-specific conformational changes in the alpha1 glycine receptor ligand-binding domain. J. Biol. Chem. 284, 15847–15856 (2009).
Fakhfouri, G., Rahimian, R., Dyhrfjeld-Johnsen, J., Zirak, M. R. & Beaulieu, J.-M. 5-HT3 Receptor antagonists in neurologic and neuropsychiatric disorders: the iceberg still lies beneath the surface. Pharmacol. Rev. 71, 383–412 (2019).
Hassaine, G. et al. Large scale expression and purification of the mouse 5-HT3 receptor. Biochim. Biophys. Acta 1828, 2544–2552 (2013).
Hassaïne, G. et al. Expression, biochemistry, and stabilization with camel antibodies of membrane proteins: case study of the mouse 5-HT3 receptor. Methods Mol. Biol. 1635, 139–168 (2017).
Grychowska, K. et al. Superiority of the triple-acting 5-HT6R/5-HT3R antagonist and MAO-B reversible inhibitor PZ-1922 over 5-HT6R antagonist intepirdine in alleviation of cognitive deficits in rats. J. Med. Chem. 66, 14928–14947 (2023).
Uchański, T. et al. Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM. Nat. Methods 18, 60–68 (2021).
Kandiah, E. et al. CM01: a facility for cryo-electron microscopy at the European Synchrotron. Acta Crystallogr D. Struct. Biol. 75, 528–535 (2019).
Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. https://doi.org/10.1038/s42003-019-0437-z (2019).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Croll, T. I. & Read, R. J. Adaptive Cartesian and torsional restraints for interactive model rebuilding. Acta Crystallogr. D 77, 438–446 (2021).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Biol. Crystallogr. 66, 486–501 (2010).
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861–877 (2019).
Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997–2004 (2014).
Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone ϕ, ψ and side-chain χ1 and χ2 dihedral angles. J. Chem. Theory Comput. 8, 3257–3273 (2012).
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153, 044130 (2020).
Feller, S. E., Zhang, Y., Pastor, R. W. & Brooks, B. R. Constant pressure molecular dynamics simulation: the Langevin piston method. J. Chem. Phys. 103, 4613–4621 (1995).
Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089–10092 (1993).
Miyamoto, S. & Kollman, P. A. Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952–962 (1992).
Andersen, H. C. Rattle: A ‘velocity’ version of the shake algorithm for molecular dynamics calculations. J. Comput. Phys. 52, 24–34 (1983).
Balusek, C. et al. Accelerating membrane simulations with hydrogen mass repartitioning. J. Chem. Theory Comput. 15, 4673–4686 (2019).
Tuckerman, M., Berne, B. J. & Martyna, G. J. Reversible multiple time scale molecular dynamics. J. Chem. Phys. 97, 1990–2001 (1992).
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38, 27–8 (1996).
Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph. 14, 354–360, 376 (1996).
Cheng, Y. & Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973).
Acknowledgements
This work was supported by the Danish Council of Independent Research for Medical Sciences (grant number DFF-404-00309, A.S.K.), the Lundbeck Foundation (grant number 2017-1655 and 2012-12453, A.S.K.), the Carlsberg Foundation (A.S.K.), the ERC Starting grant 637733 Pentabrain (HN), the Fondation pour la Recherche Médicale (grant number SPF201809007073, U.L.S.), the State-Region Plan “Technological Innovations, Modeling and Personalized Medical Support” (IT2MP, to F.D.) and the European Regional Development Funds (ERDF, to F.D.). Computations were made possible through allocations at the Centre for Scientific Computing, Aarhus (SCS-Aa). We acknowledge access to the ESRF CM01 Krios microscope. The work used the platforms of the Grenoble Instruct-ERIC center (ISBG; UMS 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-05-02) and GRAL, financed within the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003). The electron microscopy facility is supported by the Rhône-Alpes Region, the FRM, the FEDER, and the GIS-IBISA. We thank L. Zarkadas for his help with cryoEM.
Author information
Authors and Affiliations
Contributions
All authors participated in research design. U.L.-S., L.J.M., D.B., L.K.L., A.J.P., Pedersen, S.C.R.L., C.C.B., S.M.L., G.S., J.N., F.D., C.C., H.N. and A.S.K. conducted experiments. B.B.-A. contributed new reagents and analytical tools. U.L.S., L.J.M., L.K.L., M.G.P., S.C.R.L., C.C.B., S.M.L., B.S., J.N., F.D., H.N. and A.S.K. performed data analysis. U.L.S., L.J.M., L.K.L., F.D., J.N., H.N. and A.S.K. wrote or contributed to the writing of the manuscript. All authors reviewed the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
B.A. is an employee and shareholder of Lundbeck A/S. The remaining authors declare no competing interests.
Peer review
Peer review information
Nature Structural & Molecular Biology thanks Jeff Abramson and Rebecca Howard for their contribution to the peer review of this work. Primary Handling Editor: Katarzyna Ciazynska, in collaboration with the Nature Structural & Molecular Biology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Nomenclature and sequence alignment.
a, Ribbon illustration of a full 5-HT3R subunit and the extracellular domain of a complementary subunit. Binding elements are indicated in colors: Loops A-C on the principal subunit, three strands and a loop D-G on the complementary subunit. b, Multiple sequence alignment of the mouse, human, rat, and guinea pig 5-HT3A receptors. Residues of interest in Loops F and C are shown in bold. c, Amino-acid percent identity matrix of mouse, human, rat and guinea 5-HT3A receptors.
Extended Data Fig. 2 Quality of the density maps.
a, m5-HT3AR, b, apo resting h5-HT3AR, c, apo active-distorted h5-HT3AR, d, h5-HT3AR in complex with VTX (detergent) and e, h5-HT3AR in complex with VTX (nanodisc) reconstructions in surface representation overlaid with the structures. From left to right: densities of the β-sheets in the ECD, densities of the Cys-loop and/or the M2–M3 loop, densities of helices M1 and M2, densities of M3 and M4, densities of M2 at the level of L9′ (L260).
Extended Data Fig. 3 Image analysis workflow, m5-HT3AR in detergent dataset.
a, Schematic of the image analysis workflow b, Example of one micrograph from the 3000 in the dataset. c, Selected 2D class averages of the final particles set. d, Side view of the final reconstruction. The sharpened 3D density map is colored according to the local resolution (FSC threshold of 0.143). e, Heat map of the angular distribution of particle projections for the reconstruction. f, Gold-standard FSC curves. The dotted line represents the 0.143 FSC threshold.
Extended Data Fig. 4 Comparative features of the m5-HT3AR and h5-HT3AR during molecular dynamics simulations.
a-b, Probability density functions (PDFs) for the surface area of the inter-subunit ECD-ECD interfaces (a) and loop C to loop D distance (b) the for human (blue) and mouse (green) during the MD simulations receptors. Loop C-D distance is calculated between center-of-mass of Ca atoms in residues 222-228 in loop C and Cα of R87 of loop D. Fitting of a Gaussian mixture model (dashed lines) were used to determine Gaussian components using the Bayesian information criterion. c, RMSF for ring A-C. Bar graphs represent the mean ± SEM (n = 25 samples). d, Time course of the RMSD of Cα atoms of the TMDs (pale colors) and the ECDs (dark colors) showing larger deviations for the human receptor TMD. e, Probability of hydrogen bond or cation/π interaction between the amine group in VTX and nearby residues N123, S177, and W178 (human residue numbering) in the simulations of human (Ph) and mouse (Pm) 5-HT3AR. f, Probability of the ring A phenyl group assuming upwards- or downwards-facing orientations. g, Average pore profile during the initial 50 ns MD simulations with backbone restraints in h5-HT3AR (dark blue) and m5-HT3AR (dark green) compared to the profiles observed during the final 50 ns without restraints (light blue and green, respectively) in the five individual simulations. Error bars represent the standard deviation. h, Time progression of the CB-CB-S-CA dihedral angle in VTX in the independent simulations (left) and the resulting PDF (right). The dihedral angle is sampled every ns in the five binding sites (colored separately in blue, green, yellow, red, and purple). The ~40-degree (resp. -40-degree) angle region represents an upward (resp. downward) orientation of phenyl A.
Extended Data Fig. 5 Overlay of the mouse VTX-bound and antagonists-bound structures.
Overlay of the m5-HT3AR structure bound to VTX (colored as in Fig. 2) to different antagonist-bound structures (colored in gray) a, palonosetron (6Y1Z), b, palonosetron (6W1Y), c, ondansetron (6W1M) and d, alosetron (6W1J). Complementary subunits ECDs were used for superimposition. The ligands are shown as sticks (VTX colored in salmon and antagonists in red). The view is similar to that of Fig. 2e. The resemblance of the VTX-bound structure with the antagonist-bound structures extends to the organization of side chains neighboring the ligand on the complementary subunit side. This extremely conserved and rigid organization of the complementary side of the binding pocket appears to be a hallmark of the 5-HT3A receptor and is also observed in serotonin-bound structures representative of an active state. Diverse chemical structures thus fit in with only a little accommodation of the binding site moiety located on the complementary subunit. The largest differences among the VTX and setron-bound receptor structures are observed for the conformation of loop C and, more importantly, in the subunit-subunit interface reorganization12,17. In other words, the quaternary structure re-arrangement dominates over tertiary structure deviations. Still, the position of the backbone of loop C shows the biggest deviation among the VTX- and antagonist-bound structures, in line with the classical notion that it acts as a flexible lid on the orthosteric site of every pLGIC.
Extended Data Fig. 6 Comparison of VTX binding site residues and ligand-interactions in human and rodent receptors and mutational analysis of determinants for VTX activity.
a, Overview of the loop segments that form the orthosteric binding site in the 5-HT3A receptor (upper panel) and the 2D ligand-protein interaction diagram of vortioxetine with the h5-HT3AR (lower panel). Binding elements are indicated in colors: Loops A-C on the principal subunit and loops D-G on the complementary subunit. b, Multiple sequence alignment of the loop sequences in mouse (green), human (blue), rat (orange), and guinea pig (red) 5-HT3A receptors. Non-conserved positions are indicated with *. The presence and type of direct molecular interaction with VTX rings A, B, and C are indicated below the alignment: Hydrophobic = HP, hydrogen bond = HB, cation/pi=CP; pi/pi=PP, polar=PO. c,d, Amino acid sequence of loops D, G, F, and C in WT and mutant human, guinea pig, and rat 5-HT3A receptors with corresponding representative traces of the current response to the 3-step sequential protocol applying twice 10 μM 5-HT and 10 μM VTX in between that defines the receptor response-phenotype. To the right is a summary of the VTX phenotype for the constructs. Bar graphs represent the mean ± SEM (n = 7 independent oocyte recordings).
Extended Data Fig. 7 Image analysis workflow, h5-HT3AR in detergent, apo dataset.
a, Schematic of the image analysis workflow b, Example of one micrograph from the 7660 in the dataset.c, Selected 2D class averages corresponding to pentameric receptors. d, Side views of the reconstructions used for model building of the apo resting (left) and the apo active-distorted conformations (right). The density-modified map is colored according to the local resolution (FSC threshold of 0.5). e, Heat map of the angular distribution of particle projections for the reconstructions. f, Gold-standard FSC curves. The dotted line represents the 0.143 FSC threshold.
Extended Data Fig. 8 Structural comparisons of human apo resting 5-HT3A receptor.
a, Conservation-colored cartoon representation of a single subunit of the h5-HT3AR. Pink positions are conserved between mouse and human and positions in cyan are non-conserved b, Cartoon representation of the h5-HT3AR with a single subunit color-coded according to the RMSD calculated from pentameric superimposition with the structure of the palonosetron-bound mouse 5-HT3A receptor (PDB 6BE1). c, Close-up view of two opposing pore helices in an overlay of the apo (PDB 8BL8) and palonosetron-bound mouse 5-HT3A receptor structures and apo human 5-HT3A receptor structure. Pore lining residues are depicted as sticks. d,e, Zooms of loop C viewed from the top in the overlay of the apo and palonosetron-bound mouse 5-HT3A receptor structures with the apo human 5-HT3A receptor structure. The difference of loop C capping is small, and may merely reflect the difficulty of modeling this flexible zone rather than relevant species differences. e, Sequence differences could also explain the small difference in capping that might produce attractive interactions between the Met223-Glu224 motif on loop C and Lys195 on the complementary subunit in the human receptors, but repulsive interaction between the Ile201-Asp202 motif on loop C and Glu173 in the mouse receptor.
Extended Data Fig. 9 Image analysis workflow, h5-HT3AR in complex with VTX, in detergent or in nanodiscs dataset.
The top panels A to F correspond to the detergent dataset, the bottom panels G-L correspond to the nanodisc dataset. a,g, Schematic of the image analysis workflow b,h, Example of one micrograph from the dataset (size 1618 micrographs for the detergent dataset, 3290 for the nanodisc dataset). c,i, Selected 2D class averages of the final particles set. d,j, Side views of the post-processed reconstructions for the whole receptor (left) and the ECD (right). The maps are colored according to the local resolution. e,k, Heat map of the angular distribution of particle projections. f,l, Gold-standard FSC curves for the extracellular domain reconstruction. The dotted line represents the 0.143 FSC threshold.
Extended Data Fig. 10 Saturation binding curves for [3H]-GR65630 at WT h5-HT3AR and h5-HT3AR-V202I.
a,b, Specific binding (circles) and non-specific (squares) binding of [3H]GR65630 to membranes from HEK293 cells expressing WT (a) and V202I mutant (b) human 5-HT3AR is shown. The incubation time was 1 h at room temperature in 10 mM HEPES buffer, pH 7.4. Granisetron (1 µM) was used to define non-specific binding. Data points represent the mean ± SEM of 3 determinations. The full line is the fit of equation [RL] = [L] Bmax/([L] + Kd) where [RL] is the specific binding, [L] is the concentration of [3H]GR65630, Bmax is the maximum binding capacity, and Kd is the dissociation constant. The estimated Kd was 0.82 ± 0.06 nM and 0.62 ± 0.05 nM for WT and V202I, respectively.
Supplementary information
Supplementary information
Recovery from VTX inhibition with Supplementary Figs. 1–3; Structure–Activity Relationship of VTX analogs with Supplementary Figs. 4 and 5; Supplementary Tables 1–3.
Supplementary Data 1
Numerical source data for Supplementary Information items.
Source data
Source Data Figs. 1, 4 and 5 and Extended Data Figs. 4 and 6
Numerical source data for all bar graphs.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
López-Sánchez, U., Munro, L.J., Ladefoged, L.K. et al. Structural determinants for activity of the antidepressant vortioxetine at human and rodent 5-HT3 receptors. Nat Struct Mol Biol (2024). https://doi.org/10.1038/s41594-024-01282-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41594-024-01282-x